Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-023190
Filing Date
2016-06-17
Accepted
2016-06-17 17:04:11
Documents
1
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3985
  Complete submission text file 0000899243-16-023190.txt   5557
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
Moran Kyle (Reporting) CIK: 0001657765 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 161720767